160 related articles for article (PubMed ID: 8384528)
1. Effects of age and of chronic antidepressant treatment on [3H]tryptamine and [3H]dihydroalprenolol binding to rat cortical membranes.
Mousseau DD; McManus DJ; Baker GB; Juorio AV; Dewhurst WG; Greenshaw AJ
Cell Mol Neurobiol; 1993 Feb; 13(1):3-13. PubMed ID: 8384528
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of antidepressants on GABAB and beta-adrenergic receptors in rat cerebral cortex.
McManus DJ; Greenshaw AJ
Biochem Pharmacol; 1991 Sep; 42(8):1525-8. PubMed ID: 1656988
[TBL] [Abstract][Full Text] [Related]
3. Changes in alpha- and beta-receptor densities in rat brain as a result of treatment with monoamine oxidase inhibiting antidepressants.
Cohen RM; Campbell IC; Dauphin M; Tallman JF; Murphy DL
Neuropharmacology; 1982 Apr; 21(4):293-8. PubMed ID: 6123960
[TBL] [Abstract][Full Text] [Related]
4. Effects of chronic antidepressant treatment on beta-adrenoceptor subtype binding in the rat cerebral cortex and cerebellum.
Paetsch PR; Greenshaw AJ
Mol Chem Neuropathol; 1993 Sep; 20(1):21-31. PubMed ID: 7902719
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of tryptamine receptors following chronic administration of clorgyline.
Martin LL; Neale RF; Wood PL
Brain Res; 1987 Sep; 419(1-2):239-43. PubMed ID: 3676728
[TBL] [Abstract][Full Text] [Related]
6. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
Alemany R; Olmos G; García-Sevilla JA
Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
[TBL] [Abstract][Full Text] [Related]
7. Effects of low- and high-dose tranylcypromine on [3H]tryptamine binding sites in the rat hippocampus and striatum.
Goodnough DB; Baker GB; Mousseau DD; Greenshaw AJ; Dewhurst WG
Neurochem Res; 1994 Jan; 19(1):5-8. PubMed ID: 8139763
[TBL] [Abstract][Full Text] [Related]
8. Antidepressant treatments, including sibutramine hydrochloride and electroconvulsive shock, decrease beta 1- but not beta 2-adrenoceptors in rat cortex.
Heal DJ; Butler SA; Hurst EM; Buckett WR
J Neurochem; 1989 Oct; 53(4):1019-25. PubMed ID: 2549191
[TBL] [Abstract][Full Text] [Related]
9. Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brain.
Olmos G; Gabilondo AM; Miralles A; Escriba PV; García-Sevilla JA
Br J Pharmacol; 1993 Mar; 108(3):597-603. PubMed ID: 8385528
[TBL] [Abstract][Full Text] [Related]
10. Effects of chronic antidepressant treatment on dopamine-related [3H]SCH 23390 and [3H]spiperone binding in the rat striatum.
Paetsch PR; Greenshaw AJ
Cell Mol Neurobiol; 1992 Dec; 12(6):597-606. PubMed ID: 1490276
[TBL] [Abstract][Full Text] [Related]
11. Regionally specific neural adaptation of beta adrenergic and 5-hydroxytryptamine2 receptors after antidepressant administration in the forced swim test and after chronic antidepressant drug treatment.
Paul IA; Duncan GE; Powell KR; Mueller RA; Hong JS; Breese GR
J Pharmacol Exp Ther; 1988 Sep; 246(3):956-62. PubMed ID: 2843636
[TBL] [Abstract][Full Text] [Related]
12. Chronic antidepressant treatment and mouse brain 3H-imipramine binding.
Severson JA; Anderson B
J Neurosci Res; 1986; 16(2):429-38. PubMed ID: 3020258
[TBL] [Abstract][Full Text] [Related]
13. Antidepressant-induced increase in high-affinity rolipram binding sites in rat brain: dependence on noradrenergic and serotonergic function.
Zhao Y; Zhang HT; O'Donnell JM
J Pharmacol Exp Ther; 2003 Oct; 307(1):246-53. PubMed ID: 12954819
[TBL] [Abstract][Full Text] [Related]
14. Chronic antidepressant drug treatment attenuates motor-suppressant effects of apomorphine without changing [3H]GBR 12935 binding.
Allison K; Paetsch PR; Baker GB; Greenshaw AJ
Eur J Pharmacol; 1993 Nov; 249(2):125-31. PubMed ID: 8287894
[TBL] [Abstract][Full Text] [Related]
15. Bupropion: a new antidepressant drug, the mechanism of action of which is not associated with down-regulation of postsynaptic beta-adrenergic, serotonergic (5-HT2), alpha 2-adrenergic, imipramine and dopaminergic receptors in brain.
Ferris RM; Beaman OJ
Neuropharmacology; 1983 Nov; 22(11):1257-67. PubMed ID: 6320035
[TBL] [Abstract][Full Text] [Related]
16. [3H]tryptamine binding sites of rat cerebral cortex: pharmacological profile and plasticity.
Graham D; Langer SZ
Neuropharmacology; 1987 Aug; 26(8):1093-7. PubMed ID: 3116448
[TBL] [Abstract][Full Text] [Related]
17. Regulation of serotonin2 (5-HT2) receptors labeled with [3H]spiroperidol by chronic treatment with the antidepressant amitriptyline.
Peroutka SJ; Snyder SH
J Pharmacol Exp Ther; 1980 Dec; 215(3):582-7. PubMed ID: 6255132
[TBL] [Abstract][Full Text] [Related]
18. Chronic administration of the antidepressants phenelzine, desipramine, clomipramine, or maprotiline decreases binding to 5-hydroxytryptamine2A receptors without affecting benzodiazepine binding sites in rat brain.
Todd KG; McManus DJ; Baker GB
Cell Mol Neurobiol; 1995 Jun; 15(3):361-70. PubMed ID: 7553735
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of beta-adrenergic and dopaminergic receptors induced by 2-phenylethylamine.
Paetsch PR; Greenshaw AJ
Cell Mol Neurobiol; 1993 Jun; 13(3):203-15. PubMed ID: 8242685
[TBL] [Abstract][Full Text] [Related]
20. Serotonin depletion unmasks serotonergic component of [3H]dihydroalprenolol binding in rat brain.
Stockmeier CA; Kellar KJ
Mol Pharmacol; 1989 Dec; 36(6):903-11. PubMed ID: 2557537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
